Table 1 Patients’ demographics.
<65 years n(%) | ≥65 years n (%) | p value | |
|---|---|---|---|
No. | 105 | 21 | |
Age (yrs), Mean ± SD | 51.8 ± 6.9 | 70.3 ± 5.1 | <0.001 |
Gender | 0.001 | ||
Male | 105 (100) | 19 (90.5) | |
Female | 0 (0) | 2 (9.5) | |
BMIa (kg/m2), Mean ± SD | 23.5 ± 3.9 | 23.1 ± 3.9 | 0.68 |
ASAb | 0.43 | ||
ASA II | 32 (30.5) | 4 (19.0) | |
ASA III | 73 (69.5) | 17 (81.0) | |
Site of primary malignancy | 0.001 | ||
Buccal | 48 (45.7) | 6 (28.6) | |
Tongue | 14 (13.3) | 2 (9.5) | |
Mandible | 0 (0) | 2 (9.5) | |
Retromolar trigone | 14 (13.3) | 1 (4.8) | |
Palate | 6 (5.7) | 0 (0) | |
Lip | 8 (7.6) | 1 (4.8) | |
Gum | 12 (11.4) | 8 (38.1) | |
Hypopharynx | 3 (2.9) | 0 (0) | |
Indication | 0.62 | ||
Tumor | 70 (66.7) | 15 (71.4) | |
Functional reconstruction | 11 (10.5) | 3 (14.3) | |
Release contracture/trismus | 16 (15.2) | 1 (4.8) | |
ORNc | 8 (7.6) | 2 (9.5) | |
Preoperative radiation | 19 (18.1) | 8 (38.1) | 0.04 |
Preoperative chemotherapy | 73 (69.5) | 9 (42.9) | 0.03 |
Preexisting disease | |||
HTNd | 22 (21.0) | 7 (33.3) | 0.22 |
Cardiovascular | 3 (2.9) | 2 (9.5) | 0.15 |
Pulmonary | 0 (0) | 0 (0) | — |
DMe | 16 (15.2) | 8 (38.1) | 0.02 |
CVAf | 3 (2.9) | 2 (9.5) | 0.15 |
Liver cirrhosis | 8 (7.6) | 4 (19.0) | 0.10 |
